Zobrazeno 1 - 10
of 36
pro vyhledávání: '"A I Chaus"'
Autor:
A. S. Rybalko, S. N. Galkina, A. S. Saryglar, A. V. Voronin, M. I. Rezyapova, N. I. Chaus, S. N. Perekhodov, N. A. Karpun
Publikováno v:
Общая реаниматология, Vol 20, Iss 4, Pp 30-38 (2024)
The aim of the study was to assess the effect of hemoadsorption with CytoSorb on the inflammatory response, respiratory failure, and mortality in patients with severe novel coronavirus infection.Materials and methods. A retrospective single-center
Externí odkaz:
https://doaj.org/article/0a133451f0d241b3b5be81405c85ee3d
Autor:
S. I. Rey, V. V. Kulabukhov, A. Yu. Popov, O. V. Nikitina, G. A. Berdnikov, T. G. Kim, S. V. Masolitin, M. A. Magomedov, O. V. Ignatenko, N. P. Krotenko, A. N. Marysheva, N. I. Chaus, L. V. Okhinko, M. S. Mendibaev, A. G. Chumachenko, A. V. Grechko, Vladimir M. Pisarev
Publikováno v:
Вестник интенсивной терапии, Iss 4 (2023)
АКТУАЛЬНОСТЬ: Септический шок считается наиболее серьезным осложнением в интенсивной медицине и сопровождается значительной летально
Externí odkaz:
https://doaj.org/article/14698d78d7ee486bade5acd994b1bf2b
Autor:
A. N. Kuzovlev, L. V. Ermokhina, N. S. Melnikova, L. B. Berikashvili, M. Ya. Yadgarov, K. K. Kadantseva, N. I. Chaus, S. N. Perekhodov, T. S. Serkova, V. V. Likhvantsev
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 19, Iss 1, Pp 6-17 (2022)
The objective: to develop a predictive model for assessing the risk of death in patients with COVID-19 admitted to the intensive care unit (ICU).Subjects and Methods. This was a single-center retrospective cohort study of hospital mortality in patien
Externí odkaz:
https://doaj.org/article/4d1c2f64864042f1bd9143b7e23dbadc
Autor:
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, I. V. Kositsyna, A. V. Golubev, N. I. Chaus, S. N. Perekhodov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 7 (2021)
Aim. To study clinical, medical history and paraclinical characteristics of patients with non-ST elevation myocardial infarction (NSTEMI) after coronavirus disease 2019 (COVID-19).Material and methods. The study included 209 patients with NSTEMI who
Externí odkaz:
https://doaj.org/article/4ef9c82ca7384803baca34bc01d6e517
Publikováno v:
Medical alphabet. :15-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7465e81b9456c80f5f5b026387fcd5da
https://doi.org/10.33667/2078-5631-2022-23-15-19
https://doi.org/10.33667/2078-5631-2022-23-15-19
Autor:
Vladimir I. Starodubov, Valery V. Beregovykh, Vasily G. Akimkin, Tatiana A. Semenenko, Svetlana V. Ugleva, Sergey N. Avdeev, Kirill A. Zykov, Tat’yana N. Trofimova, Nana V. Pogosova, Sergey N. Perekhodov, Stanislav N. Kuzin, Svetlana В. Yacyshina, Vadim V. Petrov, Kamil F. Khafizov, Dmitry V. Dubodelov, Gasan A. Gasanov, Nino Kh. Svanadze, Anna S. Cherkashina, Evgeny A. Sinitsyn, Anna V. Rvacheva, Natal’ya V. Sergeeva, Tat’yana A. Polosova, Alexandra A. Zykova, Dmitrii A. Zelenin, Mihail Yu. Gorbenko, Irina S. Rodyukova, Nikolay I. Chaus, Artem V. Snitsar
Publikováno v:
Annals of the Russian academy of medical sciences. 77:199-207
Over the two years of the novel coronavirus infection (COVID-19) pandemic, there has been an evolution of views in various fields of medicine, which has led to a powerful development of scientific research in the field of epidemiology, clinic, diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6fb1d762b436ba035797bdb34163ec
https://doi.org/10.15690/vramn2118
https://doi.org/10.15690/vramn2118
Autor:
S. N. Galkina, A. S. Rybalko, N. A. Karpun, E. A. Zolotova, S. N. Perekhodov, N. I. Chaus, V. B. Beloborodov, E. A. Evdokimov
Publikováno v:
Medical alphabet. :69-74
Introduction. Glucocorticoids are used worldwide to control hyperinflammation in hospitalized COVID‑19 patients. Nevertheless, the debate on the appropriate initiation time, effective treatment duration and modes of administration is still ongoing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604598b263e0e83d81df3833cec1b359
https://doi.org/10.33667/2078-5631-2022-9-69-74
https://doi.org/10.33667/2078-5631-2022-9-69-74
Autor:
A.A. Baeva, N. A. Karpun, S.N. Perekhodov, Artem Kuzovlev, Valery Likhvantsev, N. I. Chaus, L.V. Ermokhina, Kristina K. Kadantseva, M.Y. Yadgarov, A.S. Mityashov
Publikováno v:
Annals of Critical Care. :69-79
Introduction. Even now — a year after the pandemic announcement by WHO, there is lack of clinical evidence to confirm the efficacy of the majority of anti-COVID drugs, evenly for general and critically ill patients. Objective. To estimate the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa1ae581e2fe8023941d3392ae0058b4
https://doi.org/10.21320/1818-474x-2021-3-69-79
https://doi.org/10.21320/1818-474x-2021-3-69-79
Autor:
S.N. Perekhodov, N. A. Karpun, A. V. Voronin, N. I. Chaus, A. S. Saryglar, E. A. Evdokimov, A. S. Rybalko, A. O. Vagulin, L. V. Zabolotskaya
Publikováno v:
Medical alphabet. :71-75
Introduction. It is the recommendations for treatment of sepsis and septic shock combined with rheumatologists’ recommendations for monoclonal antibodies therapy that guide severe COVID-19 management in ICU. However, those recommendations may not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a51935240d99947599dcee0d6e2a7e6d
https://doi.org/10.33667/2078-5631-2021-17-71-75
https://doi.org/10.33667/2078-5631-2021-17-71-75
Publikováno v:
Molekulyarnaya Meditsina (Molecular medicine). 19:3-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806267eba09a64b91bc428b062a48b98
https://doi.org/10.29296/24999490-2021-04-01
https://doi.org/10.29296/24999490-2021-04-01